Research programme: cellular adhesion molecule inhibitors - MolecumeticsAlternative Names: Research programme: VCAM/VLA4 - Molecumetics
Latest Information Update: 19 Sep 2006
At a glance
- Originator Molecumetics
- Class Small molecules
- Mechanism of Action Vascular cell adhesion molecule inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 29 Oct 1999 This programme is available for licensing (http://www.molecumetics.com)
- 08 Sep 1999 Preclinical development for Asthma in USA (unspecified route)